Poly-lysine peptidomimetics having potent antimicrobial activity without hemolytic activity
- PMID: 24961649
- DOI: 10.1007/s00726-014-1778-z
Poly-lysine peptidomimetics having potent antimicrobial activity without hemolytic activity
Abstract
Diversity of sequence and structure in naturally occurring antimicrobial peptides (AMPs) limits their intensive structure-activity relationship (SAR) study. In contrast, peptidomimetics have several advantages compared to naturally occurring peptide in terms of simple structure, convenient to analog synthesis, rapid elucidation of optimal physiochemical properties and low-cost synthesis. In search of short antimicrobial peptides using peptidomimetics, which provide facile access to identify the key factors involving in the destruction of pathogens through SAR study, a series of simple and short peptidomimetics consisting of multi-Lys residues and lipophilic moiety have been prepared and found to be active against several Gram-negative and Gram-positive bacteria containing methicillin-resistant Staphylococcus aureus (MRSA) without hemolytic activity. Based on the SAR studies, we found that hydrophobicity, +5 charges of multiple Lys residues, hydrocarbon tail lengths and cyclohexyl group were crucial for antimicrobial activity. Furthermore, membrane depolarization, dye leakage, inner membrane permeability and time-killing kinetics revealed that bacterial-killing mechanism of our peptidomimetics is different from the membrane-targeting AMPs (e. g. melittin and SMAP-29) and implied our peptidomimetics might kill bacteria via the intracellular-targeting mechanism as done by buforin-2.
Similar articles
-
Advances in Development of Antimicrobial Peptidomimetics as Potential Drugs.Molecules. 2017 Aug 29;22(9):1430. doi: 10.3390/molecules22091430. Molecules. 2017. PMID: 28850098 Free PMC article. Review.
-
Non hemolytic short peptidomimetics as a new class of potent and broad-spectrum antimicrobial agents.Bioorg Med Chem Lett. 2013 Aug 15;23(16):4633-6. doi: 10.1016/j.bmcl.2013.06.016. Epub 2013 Jun 14. Bioorg Med Chem Lett. 2013. PMID: 23816372
-
Synthesis of short cationic antimicrobial peptidomimetics containing arginine analogues.J Pept Sci. 2012 Sep;18(9):567-78. doi: 10.1002/psc.2435. Epub 2012 Jul 17. J Pept Sci. 2012. PMID: 22807132
-
Lysine-Based α-Peptide/β-Peptoid Peptidomimetics: Influence of Hydrophobicity, Fluorination, and Distribution of Cationic Charge on Antimicrobial Activity and Cytotoxicity.ChemMedChem. 2017 Feb 20;12(4):312-318. doi: 10.1002/cmdc.201600553. Epub 2017 Jan 12. ChemMedChem. 2017. PMID: 28052595
-
Recent development of small antimicrobial peptidomimetics.Future Med Chem. 2012 Sep;4(14):1853-62. doi: 10.4155/fmc.12.111. Future Med Chem. 2012. PMID: 23043481 Review.
Cited by
-
Peptides and Peptidomimetics for Antimicrobial Drug Design.Pharmaceuticals (Basel). 2015 Jul 13;8(3):366-415. doi: 10.3390/ph8030366. Pharmaceuticals (Basel). 2015. PMID: 26184232 Free PMC article. Review.
-
The Continuing Threat of Methicillin-Resistant Staphylococcus aureus.Antibiotics (Basel). 2019 May 2;8(2):52. doi: 10.3390/antibiotics8020052. Antibiotics (Basel). 2019. PMID: 31052511 Free PMC article. Review.
-
Emerging Nanomedicine Therapies to Counter the Rise of Methicillin-Resistant Staphylococcus aureus.Materials (Basel). 2018 Feb 23;11(2):321. doi: 10.3390/ma11020321. Materials (Basel). 2018. PMID: 29473883 Free PMC article. Review.
-
Synthesis of Fmoc-Triazine Amino Acids and Its Application in the Synthesis of Short Antibacterial Peptidomimetics.Int J Mol Sci. 2020 May 20;21(10):3602. doi: 10.3390/ijms21103602. Int J Mol Sci. 2020. PMID: 32443730 Free PMC article.
-
Advances in Development of Antimicrobial Peptidomimetics as Potential Drugs.Molecules. 2017 Aug 29;22(9):1430. doi: 10.3390/molecules22091430. Molecules. 2017. PMID: 28850098 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
